Registry for patients with myelodysplastic syndrome in Italy

Rete Italiana Dei Registri Regionali Delle Sindromi Mielodisplastiche (MDS)

Observational Fondazione Italiana Sindromi Mielodisplastiche-ETS · NCT02808858

This study is creating a network to gather and share information about adults newly diagnosed with myelodysplastic syndrome in Italy to better understand the condition.

Quick facts

Study typeObservational
Enrollment10000 (estimated)
Ages18 Years to 106 Years
SexAll
SponsorFondazione Italiana Sindromi Mielodisplastiche-ETS Academic / other
Locations20 sites (Alessandria, AL and 19 other locations)
Trial IDNCT02808858 on ClinicalTrials.gov

What this trial studies

This observational study aims to create a network of regional registries in Italy to collect and analyze epidemiological data from adult patients newly diagnosed with myelodysplastic syndrome (MDS). By utilizing a standardized electronic case report form, the study will aggregate anonymous data from various regions, facilitating a comprehensive understanding of MDS across the country. The collected data will also be compared with international registries to enhance the knowledge base surrounding this condition.

Who should consider this trial

Good fit: Ideal candidates for this study are adults who have recently been diagnosed with myelodysplastic syndrome.

Not a fit: Patients who refuse to provide informed consent will not benefit from this study.

Why it matters

Potential benefit: If successful, this registry could improve the understanding and management of myelodysplastic syndrome, leading to better patient outcomes.

How similar studies have performed: Other similar registries have shown success in improving patient care and outcomes by aggregating data, making this approach promising.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* New diagnosis of MDS

Exclusion Criteria:

* Patient who refuse the signature of informed consent

Where this trial is running

Alessandria, AL and 19 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Myelodysplastic-Myeloproliferative DiseasesMDSMyelodisplastic Syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.